Skyrizi 150 MG/ML penml
Ended Awarded Last action
- Contract number
- SPE2DR26FJH9F
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $46,154
Award facts
- Contract value 100% obligated
- $46,154.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency (DLA) valued at $46,154.38 for SKYRIZI 150 mg/mL pen injectors. The contract is structured as a firm fixed-price delivery order with no set-aside designation, with an ultimate completion date of January 15, 2026. This award is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion vehicle that runs through December 2031 and serves as the primary procurement mechanism for pharmaceutical products and medical supplies supporting military healthcare programs globally.
The delivery order represents a routine procurement under the DLA's pharmaceutical supply chain operations, which support military treatment facilities and Department of Defense healthcare systems. SKYRIZI is a prescription biologic medication used to treat autoimmune conditions, and this order fulfills specific medical supply requirements within the DLA's broader pharmaceutical vendor program. AmerisourceBergen's extensive federal contract portfolio and competitive award history demonstrate the company's capability to efficiently deliver essential pharmaceutical commodities to support military and federal healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FJH9F?
SPE2DR26FJH9F was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FJH9F worth?
The government has obligated $46,154 on SPE2DR26FJH9F.
Is contract SPE2DR26FJH9F an order under another contract?
Yes. SPE2DR26FJH9F is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJH9F competed?
The extent of competition for SPE2DR26FJH9F was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award